IP31-28: The Diagnostic Benefit of Perilesional Sampling at the Time of Confirmatory Biopsy in Patients Managed with Active Surveillance for ISUP-GG 1 Prostate Cancer

IP31-28: The Diagnostic Benefit of Perilesional Sampling at the Time of Confirmatory Biopsy in Patients Managed with Active Surveillance for ISUP-GG 1 Prostate Cancer

Saturday, May 16, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)

145AB

Abstract

Speakers

Leonardo Quarta

Sessions

IP31: Prostate Cancer: Localized: Active Surveillance

Saturday, May 16, 2026 9:30 AM to 11:30 AM

Aria Olumi · Janet & William Dewolf Professor of Urology

LARA RODRIGUEZ SANCHEZ · Institut Médico-chirurgical Montsouris

Rafael Sanchez-Salas · McGill University

Log in

See all the content and easy-to-use features by logging in or registering!